Direct antimicrobial properties of substance P

被引:64
作者
Kowalska, K
Carr, DB
Lipkowski, AW
机构
[1] Ind Chem Res Inst, PL-01793 Warsaw, Poland
[2] Tufts Univ, Boston, MA 02111 USA
[3] Tufts Univ New England Med Ctr, Boston, MA 02111 USA
[4] Polish Acad Sci, Med Res Ctr, PL-02106 Warsaw, Poland
关键词
substance P; substance P antagonist; antimicrobial agents;
D O I
10.1016/S0024-3205(02)01740-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The structural similarity between substance P (SP, Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2) and Arg/Pro rich bactericidal peptides suggests a possible direct effect of SP on invasive microbes. We now present evidence that substance P possesses direct antimicrobial activity, highest against S. aureus. A substance P antagonist also possesses such activity but while less potent than substance P agonist S. aureus, is more potent than substance P against C albicans. Our data also show that the endogenous peptides bradykinin and neurotensin, that also play role in modulation of the host-defense system in situ, have antimicrobial properties but are less potent than substance P. (C) 2002 Published by Elsevier Science Inc.
引用
收藏
页码:747 / 750
页数:4
相关论文
共 14 条
[1]   AMINO-ACID-SEQUENCE OF PR-39 - ISOLATION FROM PIG INTESTINE OF A NEW MEMBER OF THE FAMILY OF PROLINE-ARGININE-RICH ANTIBACTERIAL PEPTIDES [J].
AGERBERTH, B ;
LEE, JY ;
BERGMAN, T ;
CARLQUIST, M ;
BOMAN, HG ;
MUTT, V ;
JORNVALL, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 202 (03) :849-854
[2]   DESIGN AND SYNTHESIS OF EFFECTIVE ANTAGONISTS OF SUBSTANCE-P [J].
FOLKERS, K ;
HORIG, J ;
RAMPOLD, G ;
LANE, P ;
ROSELL, S ;
BJORKROTH, U .
ACTA CHEMICA SCANDINAVICA SERIES B-ORGANIC CHEMISTRY AND BIOCHEMISTRY, 1982, 36 (06) :389-395
[3]  
HARTUNG HP, 1986, J IMMUNOL, V136, P3856
[4]   Substance P augments nitric oxide production and gene expression in murine macrophages [J].
Jeon, HK ;
Jung, NP ;
Choi, IH ;
Oh, YK ;
Shin, HC ;
Gwag, BJ .
IMMUNOPHARMACOLOGY, 1999, 41 (03) :219-226
[5]   Pro-inflammatory effects of substance P: new perspectives for the treatment of airway diseases? [J].
Joos, GF ;
Pauwels, RA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (04) :131-133
[6]   IDENTIFICATION OF IMMUNOREACTIVE SUBSTANCE-P IN HUMAN AND OTHER MAMMALIAN ENDOTHELIAL-CELLS [J].
LINNIK, MD ;
MOSKOWITZ, MA .
PEPTIDES, 1989, 10 (05) :957-962
[7]  
MASZCZYNSKA I, 2000, ANALGESIA, V3, P259
[8]   TOPOGRAPHICAL REQUIREMENTS FOR DELTA-OPIOID LIGANDS - PRESENCE OF A CARBOXYL GROUP IN POSITION-4 IS NOT CRITICAL FOR DELTORPHIN HIGH DELTA-RECEPTOR AFFINITY AND ANALGESIC ACTIVITY [J].
MISICKA, A ;
LIPKOWSKI, AW ;
FANG, L ;
KNAPP, RJ ;
DAVIS, P ;
KRAMER, T ;
BURKS, TF ;
YAMAMURA, HI ;
CARR, DB ;
HRUBY, VJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 180 (03) :1290-1297
[9]  
PASCUAL DW, 1990, IMMUNOLOGY, V71, P52
[10]  
PAYAN DG, 1989, ANNU REV MED, V40, P341